The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Tuesday, May 2, 2017

New breast cancer study will assess controversial 'watchful waiting' approach according to : Chicago Tribune

And from the reduced use of antibiotics to the dialing back of radiation and chemotherapy for breast Cancer, "there's a sea change going on." "I wish I had breasts, but I am also happy they are gone so that I don't have to worry so much about breast cancer," says Nickles, whose grandmother had the disease. Barbara Nickles and Ligia Toro de Stefani are both women in their early 60s who were diagnosed with abnormal cells in a breast, or Stage 0 breast cancer as it's sometimes labeled. Shelley Hwang, chief of breast surgery at the Duke Cancer Institute, said COMET reflects the growing realization that DCIS, like breast cancer itself, represents a range of subtypes of abnormal cells and that treatments need to be tailored to individual risks. Most say the condition, while not cancer, needs aggressive treatment because 20 percent to 30 percent of cases will spread to surrounding tissue and become invasive cancer if left alone.



New breast cancer study will assess controversial 'watchful waiting' approach
ROCKWALL – Breast Cancer doesn't always present itself as a tumor or lump. Inflammatory Breast Cancer," she said. Medicine cannot stop her inflammatory breast cancer but has successfully slowed it down. "I remember him saying 'inflammatory breast cancer.' For Jennifer Cordts, it was a tinge of redness similar to a sunburn on the side of one of her breasts.

Low-dose aspirin may cut breast cancer risk by a fifth

After skin cancer, breast cancer is the most common cancer among women in the United States. HER2 status is whether or not breast cancer cells contains too many HER2 receptors, which can fuel breast cancer growth. However, according to Bernstein and colleagues, few studies have investigated the effects of aspirin use on the risk of certain breast cancer subtypes, and it has been unclear as to whether low-dose aspirin, or "baby" aspirin, protects against breast cancer. Researchers have found a link between low-dose aspirin and reduced risk of breast cancer. Looking at breast cancer subtypes, the team found that the risk of developing HR-positive/HER2-negative breast cancer was 20 percent lower for women who took low-dose aspirin at least three times per week.


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases

No comments:

Post a Comment